Dr James Januzzi from Massachusetts General Hospital discusses the new consensus statement on heart failure, biomarker testing for diagnosing heart failure, and potential future treatments.
<p>Dr Thomas Seck from Boehringer Ingelheim Pharmaceuticals discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.</p>
Corrine Voils, MD, from Williams S. Middleton Memorial Veterans Hospital and Wisconsin School of Medicine and Public Health, discusses her latest research paper about the myths of medication adherence.
...
Dr Seth Baum, president of the American Society for Preventive Cardiology, welcomes you to our new podcast series and leaves clinicians with a tip for gaining access to heart failure medication.
Dr Raymond Cho, from Baylor College of Medicine, discusses the upcoming SARDAA conference on schizophrenia and his outlook on mental health in the United States.
Dr Joel Gelfand, from the University of Pennsylvania, discusses his latest research on the interaction between psoriasis and diabetes, as well as other comorbidities.
<p>Dr Angela Campbell, from the Centers for Disease Control and Prevention, speaks with us about this year's influenza season, as well as what health care providers should know about diagnosing...
Justin Glenn, MD, from Johns Hopkins School of Medicine, discusses his latest research paper about "The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease."
